精神病患者的自杀死亡和其他原因死亡率:韩国一项使用全国索赔数据的研究
Minha Hong1, Sang Min Lee2, Kyu-Man Han3
1Department of Psychiatry, Myongji Hospital, Hanyang University College of Medicine, 55 Hwasu-ro 14 beon-gil, Deogyang-gu, Goyang 10475, South Korea; UNC Neuroscience Center, University of North Carolina, Chapel Hill, NC, USA.
Journal of affective disorders
|February 22, 2024
概括
精神病患者面临高的自杀和死亡率. 这项研究分析了95,855名患者,发现抑郁症,酒精使用障碍,精神分裂症和双相情感障碍增加了自杀风险,突出了医疗保健专业培训的必要性.
科学领域:
- 精神病学是一个精神病学.
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 高度的自杀和过度的死亡率是精神疾病患者的重大问题.
- 了解死亡原因和风险因素对于改善心理健康护理至关重要.
研究的目的:
- 研究被诊断患有重大精神疾病的患者的自杀和其他原因死亡率.
- 确定与死亡率相关的因素,包括医疗保健利用模式.
主要方法:
- 用国家医疗保险索赔数据进行回顾性,基于人口的队列研究.
- 纳入标准:首次入院主要诊断为严重精神疾病 (2010-2011).
- 随访到2020年,使用Log-rank测试和卡普兰-梅尔曲线评估死亡率.
主要成果:
- 分析了95855名患者 (平均年龄为48.2岁) 的队列.
- 自杀死亡人数:2408人 (288.1/10万人/年);因其他原因死亡人数:15,192人 (1817.6/10万人/年).
- 抑郁症的自杀风险最高,其次是酒精使用障碍,精神分裂症和双相情感障碍. 在自杀事件之前,医疗保健的使用率很高.
结论:
- 医疗保健的利用与精神病患者的自杀和其他死因有关.
- 为医疗保健专业人员实施像"守门人"计划这样的计划对于预防自杀至关重要.
- 对前线工作人员,精神病医生和医生进行有针对性的教育可以减轻自杀风险.
相关概念视频
Kaplan-Meier Approach
138
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
138
Psychosurgery
55
Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
55
Actuarial Approach
78
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
78
Introduction To Survival Analysis
236
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
236
Comparing the Survival Analysis of Two or More Groups
186
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
186
Cancer Survival Analysis
346
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
346


